The government is considering introducing a dengue vaccine as a long-term measure to reduce infections and deaths, but there are no immediate plans to vaccinate people against dengue, State Minister for Health Dr MA Muhit said on Tuesday.
“We are discussing vaccines as a long-term measure. There are probably three dengue vaccine candidates in the world at present. We are also considering the issue in Bangladesh, but it is not happening at this moment,” he said.
The state minister made the remarks at a seminar on tackling the dengue crisis at Holy Family Red Crescent Medical College Hospital in Dhaka. The Doctors Association of Bangladesh (DAB) organised the event.
All dengue variants found in Bangladesh
Dr Muhit said Bangladesh has all dengue variants, describing it as a “unique scientific finding.”
He said while one or two variants are generally dominant in many countries, all variants have been detected in Bangladesh.
Referring to his recent visit to Japan, he said the country also has a dengue vaccine candidate and Bangladesh is discussing the issue. However, further research and trials are needed before any decision is made on vaccination.
Govt steps up prevention efforts
Dr Muhit stressed prevention as the main way to reduce dengue infections and deaths, particularly by eliminating Aedes mosquito breeding grounds.
He said public participation is essential to destroy mosquito larvae, as neither the government nor any single organisation can keep the entire country clean.
Clean-up drives are underway in neighbourhoods, educational institutions and government offices, while local government bodies are working to destroy mosquito larvae and control mosquitoes, he added.
2,000 doctors receive updated training
The government is also focusing on early diagnosis, prompt referral and improved treatment for infected patients, Dr Muhit said.
He said around 2,000 doctors across the country have received updated training in dengue management over the past two months.
A clinical management guideline for dengue patients is also being circulated with support from the Society of Medicine.
“Good clinical management after infection can reduce the death rate,” he said.